Eli Lilly Aktie 947556 / US5324571083
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
03.11.2025 10:45:00
|
Prediction: The Next Eli Lilly Might Already Be Trading Under $50
Eli Lilly (NYSE: LLY) produced exceptional returns over the long run and is now the largest pharmaceutical company in the world by market cap, largely thanks to its work in diabetes drugs and, more recently, weight management. The company's shares are currently trading at about $860, but what if we could invest in the next Eli Lilly now at a fraction of that price?One strong candidate for future pharmaceutical greatness is Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech with large-cap ambitions. Viking Therapeutics doesn't have any products on the market yet, but its leading drug candidate, VK2735, looks promising. This investigational weight loss medicine mimics the actions of the GLP-1 and GIP hormones, both of which help control blood sugar levels. So far, the only dual GLP-1/GIP agonist approved by the Food and Drug Administration is Eli Lilly's tirzepatide, a therapy that is smashing pharmaceutical industry sales records, marketed as Mounjaro and Zepbound.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Nachrichten zu Eli Lilly
|
28.11.25 |
S&P 500-Handel aktuell: S&P 500 präsentiert sich schlussendlich fester (finanzen.ch) | |
|
28.11.25 |
Zuversicht in New York: S&P 500 zeigt sich am Nachmittag fester (finanzen.ch) | |
|
28.11.25 |
Gute Stimmung in New York: Anleger lassen S&P 500 am Freitagmittag steigen (finanzen.ch) | |
|
28.11.25 |
Eli Lilly Aktie News: Eli Lilly am Freitagnachmittag mit Kursverlusten (finanzen.ch) | |
|
28.11.25 |
Aufschläge in New York: S&P 500 klettert zum Handelsstart (finanzen.ch) | |
|
26.11.25 |
Eli Lilly Aktie News: Eli Lilly am Mittwochabend im Minusbereich (finanzen.ch) | |
|
25.11.25 |
S&P 500-Wert Eli Lilly-Aktie: So viel Gewinn hätte eine Investition in Eli Lilly von vor 5 Jahren abgeworfen (finanzen.ch) | |
|
21.11.25 |
Eli Lilly becomes first pharma group to join $1tn club (Financial Times) |